Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 16714-825

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 16714-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier survival curve chart showing the proportion of patients without events over time (days) for propafenone hydrochloride extended-release capsules at 225 mg, 325 mg, and 425 mg doses compared to placebo. The graph includes statistical significance values (p values) and a risk table indicating the number of patients at risk at various time points.*

FDA Label Image

Propafenone-225mg-60-capsules.jpg (Propafenone 225mg 60 Capsules)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP, 225 mg strength. The label indicates a package of 60 capsules. Manufactured for Northstar Rx LLC, Memphis, TN, and by Glenmark Pharmaceuticals Ltd., India. Directions include storage instructions, dosage reference, and a caution about seal integrity.*

FDA Label Image

Propafenone-325mg-60-capsules.jpg (Propafenone 325mg 60 Capsules)

Label for Propafenone Hydrochloride Extended-Release Capsules USP, 325 mg strength, 60 capsules per bottle. The label indicates the product is manufactured for Northstar Rx LLC and by Glenmark Pharmaceuticals Ltd. It includes storage instructions, dosage form, and a barcode. The capsules are for oral use.*

FDA Label Image

Propafenone-425mg-60-capsules.jpg (Propafenone 425mg 60 Capsules)

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 425 mg, in a 60-capsule package. The label states the product is manufactured for Northstar Rx LLC and by Glenmark Pharmaceuticals Ltd., with storage instructions and a barcode included.*

FDA Label Image

Structure (Structure)

Chemical structure of propafenone hydrochloride, showing its molecular composition including aromatic rings, hydroxyl group, and hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.